BMS-351
Product Specifications
CAS Number
1370001-71-0
Target
Cytochromes P450, Others
Related Pathways
Others, Metabolism
Bioactivity
BMS-351 is a potent and selective, nonsteroidal CYP17A1 lyase inhibitor with robust selectivity over steroidogenic CYPs 21A2 and 11B1. BMS-351 emerges as an outstanding preclinical candidate to treat CRPC and is likely to minimize the side effects of current therapies due to its exceptional selectivity. BMS-351 is potentially useful for the Treatment of Prostate Cancer.
Smiles
C(C(F)(F)F)N1C=2C(=C(C=CC2)C=3C(C)=CC=NC3)N=C1
Molecular Formula
C15H12F3N3
Molecular Weight
291.27
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7046837 Inquire
N-terminal 10xHis-B2M-JD-tag and C-terminal Myc-tag
Sign In for Pricing
View Details 
PA1615-Fluoro594 100 µg/Vial
Anti-IL2 Receptor beta/IL2RB Antibody Picoband® Fluoro594 Conjugated
Sign In for Pricing
View Details